Stockreport

Celldex Tumbles On Phase 2 Trial Failure; Is There Any Value Left? [Seeking Alpha]

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF Celldex Tumbles On Phase 2 Trial Failure; Is There Any Value Left?SummaryCelldex fails to meet primary endpoint for phase 2 trial treating patients with metastatic tripl [Read more]